AACC会议展示更好检测心脏病突发的新检验产品和新研究
|
By LabMedica International staff writers Posted on 26 Oct 2015 |

图片A:i-Stat TOTAL ß-hCG——第一款且是唯一的一款手持式怀孕血检(图片取自雅培护理点i-Stat)。

图片B:Xprecia Stride凝集分析仪(图片蒙西门子医疗集团诊断部惠赐)。
7月26-30日于美国佐治亚州亚特兰大市举行的2015 AACC年会暨临床化验博览会是全球医疗化验专家的顶级盛会,展览的重点是更好地检测心脏病突发的新型临床检验产品和实时研究。还展示了更快、更简便检验的新型手持式技术。
本届会议举办了400多场培训会,主题涵盖个性化医疗、传染病、床旁检验和实验室自主开发检验等,还展示了200多种最新型的诊断产品。
除研讨会、全体会议、课程和展板外,AACC 2015大会还展示了史无前例的实时研究实验,该实验改进了识别心脏病突发及其未来发病风险的检验方法。这项突破性科学行动改进了心脏病突发的检验,与会者有机会参与其中并现场提供血样供研究。这项行动的目标是确立健康成人肌钙蛋白的基线值。这项研究有助于急诊室更快地区分心脏病突发与症状类似的其它病症,更好地识别心血管事件风险较高的病人。
展商展示了床旁诊断检验的最新产品以及更微创、更快、更便宜的检验产品。其中之一是雅培护理点i-STAT Total β-hCG,这是第一款且是唯一的一款手持式怀孕血检。研究显示,在怀孕的头几周,11种最流行的医院用怀孕尿检里有9种不可靠。在急诊场合,这项新血检对准确判定女性的怀孕状态发挥至关重要的作用,根据怀孕状态确定如何实施治疗,以免伤害婴儿。美国纽约州Tarrytown西门子医疗集团诊断部的Xprecia Stride凝集分析仪荣获2015年产品设计红点奖。这款手持式仪器第一次让医疗工作者能在门诊看病的过程中确定正在接受薄血疗法治疗以预防心脏病突发与脑卒中的患者是否处于不可控失血的风险。
AACC年会共持续了5天,与会者有机会学习一些令人兴奋的科学知识。全体会议上专家报告的主题有:血液中的肿瘤DNA诊断和监测癌症,减小心脏病风险,医疗服务的透明化,HIV治疗的最新进展,针对感染的新检验和新疗法。在AACC临床化验博览会上,700多家展商布满了佐治亚世界会议中心亚特兰大会展中心的展厅,展示的最新诊断技术包括移动医疗、分子诊断、质谱、护理点、自动化等等。
Related Links:
美国临床化学协会(AACC)
AACC 2015年会暨临床化验博览会
本届会议举办了400多场培训会,主题涵盖个性化医疗、传染病、床旁检验和实验室自主开发检验等,还展示了200多种最新型的诊断产品。
除研讨会、全体会议、课程和展板外,AACC 2015大会还展示了史无前例的实时研究实验,该实验改进了识别心脏病突发及其未来发病风险的检验方法。这项突破性科学行动改进了心脏病突发的检验,与会者有机会参与其中并现场提供血样供研究。这项行动的目标是确立健康成人肌钙蛋白的基线值。这项研究有助于急诊室更快地区分心脏病突发与症状类似的其它病症,更好地识别心血管事件风险较高的病人。
展商展示了床旁诊断检验的最新产品以及更微创、更快、更便宜的检验产品。其中之一是雅培护理点i-STAT Total β-hCG,这是第一款且是唯一的一款手持式怀孕血检。研究显示,在怀孕的头几周,11种最流行的医院用怀孕尿检里有9种不可靠。在急诊场合,这项新血检对准确判定女性的怀孕状态发挥至关重要的作用,根据怀孕状态确定如何实施治疗,以免伤害婴儿。美国纽约州Tarrytown西门子医疗集团诊断部的Xprecia Stride凝集分析仪荣获2015年产品设计红点奖。这款手持式仪器第一次让医疗工作者能在门诊看病的过程中确定正在接受薄血疗法治疗以预防心脏病突发与脑卒中的患者是否处于不可控失血的风险。
AACC年会共持续了5天,与会者有机会学习一些令人兴奋的科学知识。全体会议上专家报告的主题有:血液中的肿瘤DNA诊断和监测癌症,减小心脏病风险,医疗服务的透明化,HIV治疗的最新进展,针对感染的新检验和新疗法。在AACC临床化验博览会上,700多家展商布满了佐治亚世界会议中心亚特兰大会展中心的展厅,展示的最新诊断技术包括移动医疗、分子诊断、质谱、护理点、自动化等等。
Related Links:
美国临床化学协会(AACC)
AACC 2015年会暨临床化验博览会
Latest 行业新闻 News
Channels
Clinical Chemistry
view channel
New PSA-Based Prognostic Model Improves Prostate Cancer Risk Assessment
Prostate cancer is the second-leading cause of cancer death among American men, and about one in eight will be diagnosed in their lifetime. Screening relies on blood levels of prostate-specific antigen... Read more
Extracellular Vesicles Linked to Heart Failure Risk in CKD Patients
Chronic kidney disease (CKD) affects more than 1 in 7 Americans and is strongly associated with cardiovascular complications, which account for more than half of deaths among people with CKD.... Read moreMolecular Diagnostics
view channel
Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test
Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more
Blood Test Detects Early-Stage Cancers by Measuring Epigenetic Instability
Early-stage cancers are notoriously difficult to detect because molecular changes are subtle and often missed by existing screening tools. Many liquid biopsies rely on measuring absolute DNA methylation... Read more
“Lab-On-A-Disc” Device Paves Way for More Automated Liquid Biopsies
Extracellular vesicles (EVs) are tiny particles released by cells into the bloodstream that carry molecular information about a cell’s condition, including whether it is cancerous. However, EVs are highly... Read more
Blood Test Identifies Inflammatory Breast Cancer Patients at Increased Risk of Brain Metastasis
Brain metastasis is a frequent and devastating complication in patients with inflammatory breast cancer, an aggressive subtype with limited treatment options. Despite its high incidence, the biological... Read moreHematology
view channel
New Guidelines Aim to Improve AL Amyloidosis Diagnosis
Light chain (AL) amyloidosis is a rare, life-threatening bone marrow disorder in which abnormal amyloid proteins accumulate in organs. Approximately 3,260 people in the United States are diagnosed... Read more
Fast and Easy Test Could Revolutionize Blood Transfusions
Blood transfusions are a cornerstone of modern medicine, yet red blood cells can deteriorate quietly while sitting in cold storage for weeks. Although blood units have a fixed expiration date, cells from... Read more
Automated Hemostasis System Helps Labs of All Sizes Optimize Workflow
High-volume hemostasis sections must sustain rapid turnaround while managing reruns and reflex testing. Manual tube handling and preanalytical checks can strain staff time and increase opportunities for error.... Read more
High-Sensitivity Blood Test Improves Assessment of Clotting Risk in Heart Disease Patients
Blood clotting is essential for preventing bleeding, but even small imbalances can lead to serious conditions such as thrombosis or dangerous hemorrhage. In cardiovascular disease, clinicians often struggle... Read moreImmunology
view channelBlood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug
Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more
Whole-Genome Sequencing Approach Identifies Cancer Patients Benefitting From PARP-Inhibitor Treatment
Targeted cancer therapies such as PARP inhibitors can be highly effective, but only for patients whose tumors carry specific DNA repair defects. Identifying these patients accurately remains challenging,... Read more
Ultrasensitive Liquid Biopsy Demonstrates Efficacy in Predicting Immunotherapy Response
Immunotherapy has transformed cancer treatment, but only a small proportion of patients experience lasting benefit, with response rates often remaining between 10% and 20%. Clinicians currently lack reliable... Read moreMicrobiology
view channel
Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease
Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read moreAI-Powered Platform Enables Rapid Detection of Drug-Resistant C. Auris Pathogens
Infections caused by the pathogenic yeast Candida auris pose a significant threat to hospitalized patients, particularly those with weakened immune systems or those who have invasive medical devices.... Read morePathology
view channel
Engineered Yeast Cells Enable Rapid Testing of Cancer Immunotherapy
Developing new cancer immunotherapies is a slow, costly, and high-risk process, particularly for CAR T cell treatments that must precisely recognize cancer-specific antigens. Small differences in tumor... Read more
First-Of-Its-Kind Test Identifies Autism Risk at Birth
Autism spectrum disorder is treatable, and extensive research shows that early intervention can significantly improve cognitive, social, and behavioral outcomes. Yet in the United States, the average age... Read moreTechnology
view channel
Robotic Technology Unveiled for Automated Diagnostic Blood Draws
Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more
ADLM Launches First-of-Its-Kind Data Science Program for Laboratory Medicine Professionals
Clinical laboratories generate billions of test results each year, creating a treasure trove of data with the potential to support more personalized testing, improve operational efficiency, and enhance patient care.... Read moreAptamer Biosensor Technology to Transform Virus Detection
Rapid and reliable virus detection is essential for controlling outbreaks, from seasonal influenza to global pandemics such as COVID-19. Conventional diagnostic methods, including cell culture, antigen... Read more
AI Models Could Predict Pre-Eclampsia and Anemia Earlier Using Routine Blood Tests
Pre-eclampsia and anemia are major contributors to maternal and child mortality worldwide, together accounting for more than half a million deaths each year and leaving millions with long-term health complications.... Read moreIndustry
view channelNew Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing
Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
AI-Powered Cervical Cancer Test Set for Major Rollout in Latin America
Noul Co., a Korean company specializing in AI-based blood and cancer diagnostics, announced it will supply its intelligence (AI)-based miLab CER cervical cancer diagnostic solution to Mexico under a multi‑year... Read more
Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform
Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more







